Hillsdale and COVID-19
Hillsdale is taking measures to ensure the safety of our clients and staff, while remaining dedicated to providing ongoing services.
April 6, 2020
“We’ll get through it”: A physician and venture capitalist on Coronavirus
Laurence B. Siegel interviews Dr. Drew Senyei, a medical doctor who has spent much of his life starting and growing biotechnology companies.
March 23, 2020
Hillsdale adds COVID risk factor to performance attribution for portfolio management as well as quarterly reporting to clients.
March 13, 2020
Hillsdale creates a COVID vector distinct from market and oil price shocks to analyze the effect of COVID-19 on the prices of our holdings.
March 12, 2020
Hillsdale begins virtual audit of each of our 36 staff member’s home offices. The list of home audits includes installation of proper firewall, updated anti-virus, security patches and checking of local bandwidth consistency and availability. All staff were provided three redundant routes to access Hillsdale’s data and communication infrastructure. These access points are monitored real time with bottlenecks addressed as quickly as possible. Any necessary hardware upgrades and replacements are in process or on order.
March 9, 2020
Updated Work From Home Policy and Checklist distributed to all staff and we enacted our Business Continuity Plan with the following objectives:
- To ensure the safety of all Hillsdale staff;
- To ensure the security of client assets and information;
- To maintain our high standards of responsiveness to client concerns;
- To ensure the maintenance of Hillsdale’s full resources and capabilities to properly manage our clients’ portfolios; and
- To ensure that Hillsdale will continue to conduct its business efficiently and effectively for a long time to come.
March 8, 2020
Hillsdale forms a COVID working group which meets every two days via conference call.
March 5, 2020
A staff wiki set up to collect and share COVID information internally.
February 24, 2020
Hillsdale begins review of its Work From Home and Communicable Disease policies.